Production, purification and some properties of Bac201, a bacteriocin-like inhibitory substance produced by Staphylococcus aureus AB201

Journal of Basic Microbiology
A IqbalS A Rasool

Abstract

Staphylococcus aureus AB201, a clinical isolate from wound pus, produced a bacteriocin-like inhibitory substance termed as Bac201, that was inhibitory to Streptococcus agalactiae, Enterococcus faecalis, Acinetobacter calcoaceticus, Neisseria meningitidis and a number of staphylococcal species. It was purified to homogeneity by ammonium sulfate precipitation, gel filtration (BioSil-SEC-125), and reversed-phase high performance liquid chromatography (Vydac C4). The native Bac201 was sized at approximately 170-kDa as determined by GF HPLC. Fraction-I (native Bac201), having antibacterial activity was also examined by transmission electron microscopy and appeared as globular structure showing resemblance with phage-like objects. The purification of Bac201 resulted in 466-fold increase in specific activity and recovery of 0.94% of total antibacterial activity. The purified Bac201 migrated as single band on SDS-PAGE with an estimated molecular mass of about 41-kDa. Bac201 was sensitive to proteolytic enzymes, resistant to heat and organic solvents, and active over a wide range of pH (2.5-10). The amino acid composition revealed a general resemblance with other reported high molecular mass bacteriocins and predominance of glycine (39%...Continue Reading

References

Jan 1, 1991·Applied and Environmental Microbiology·P M Muriana, T R Klaenhammer
Aug 1, 1989·Applied and Environmental Microbiology·U Schillinger, F K Lücke
Sep 1, 1989·The Science of the Total Environment·K J JohansonJ Bertilsson
Oct 1, 1986·European Journal of Biochemistry·H AllgaierH Zähner
Jul 1, 1973·Antimicrobial Agents and Chemotherapy·A M Jetten, G D Vogels
Dec 1, 1973·Antimicrobial Agents and Chemotherapy·E M Hale, R D Hinsdill
Oct 1, 1970·Journal of Bacteriology·V J Gagliano, R D Hinsdill
Jun 15, 1995·European Journal of Biochemistry·H G SahlG Bierbaum
Dec 1, 1996·Micron : the International Research and Review Journal for Microscopy·M A Daw, F R Falkiner
Jan 1, 1997·Journal of Basic Microbiology·C M FranzW H Holzapfel
Dec 3, 1998·Applied and Environmental Microbiology·M A NavaratnaJ R Tagg

❮ Previous
Next ❯

Citations

Oct 8, 2005·Current Microbiology·G BhuvaneswariHemant J Purohit
Feb 20, 2014·International Journal for Numerical Methods in Biomedical Engineering·Lin QiMax Q Meng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.